The Tyrer-Cuzick model (also known as the IBIS risk assessment tool) was developed to evaluate the individual risk of BC over time, but also provides an estimate of the probability of finding BRCA1/BRCA2 PGVs. This evidence concerns the gene BRCA2 and breast cancer.